UCB
Yoshinobu Hayakawa is an experienced professional in clinical pharmacology with a strong background in drug development and pharmacokinetics. Currently serving as a Senior Manager in Clinical Pharmacology at UCB since October 2020, Yoshinobu previously held positions at Hisamitsu Pharmaceutical Co., Inc. as a Section Manager and at Noven Pharmaceuticals as a PK Studies Project Manager. With expertise spanning from Phase I studies to regulatory support and bioanalytical method validation, Yoshinobu has been instrumental in advancing pharmaceutical research and development. Yoshinobu holds a Master's degree in Pharmacy from Tokyo University of Pharmacy and Life Sciences.
This person is not in any teams
This person is not in any offices
UCB
48 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.